PIK3CB and esophageal squamous cell carcinoma: At the same time, they found that BEZ235 combined with Trichostatin A(histone deacetylase inhibitor) had better tumor inhibition effect than single drug (102).Clinical trials of dual PI3K and mTOR inhibitors have not been conducted in the ESCC.